<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
  <id>https://recalls.watch/feed/substance-atorvastatin.xml</id>
  <title>Recalls Watch: Atorvastatin</title>
  <link rel="self" href="https://recalls.watch/feed/substance-atorvastatin.xml"/>
  <link href="https://recalls.watch/alerts/"/>
  <updated>2026-11-04T00:00:00Z</updated>
  <entry>
    <id>https://recalls.watch/recall/fda/100172/</id>
    <title>MSN Laboratories Private Limited (Formulations Division, Unit-II): Atorvastatin Calcium Tablets</title>
    <link href="https://recalls.watch/recall/fda/100172/"/>
    <updated>2026-11-04T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Presence of Foreign Tablets/Capsules</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/97639/</id>
    <title>Ascend Laboratories, LLC: Atorvastatin Calcium Tablets USP and 3 more</title>
    <link href="https://recalls.watch/recall/fda/97639/"/>
    <updated>2025-10-22T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Failed Dissolution Specifications</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/96496/</id>
    <title>BIOCON PHARMA INC: Atorvastatin Calcium Tablets USP 40 mg</title>
    <link href="https://recalls.watch/recall/fda/96496/"/>
    <updated>2025-04-09T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Failed dissolution specifications: lower than specifications</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/95418/</id>
    <title>Nivagen Pharmaceuticals Inc: Atorvastatin Calcium Tablets</title>
    <link href="https://www.accessdata.fda.gov/scripts/ires/index.cfm?Event=95418"/>
    <updated>2024-10-09T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Presence of Foreign Tablets/Capsules: A Carbamazepine Extended-Release 400 mg tablet was found in a 1000-count bottle of Atorvastatin Calcium Tablets, USP 40 mg.</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/91944/</id>
    <title>Northwind Pharmaceuticals LLC: Atorvastatin Calcium Tablets and 6 more</title>
    <link href="https://www.accessdata.fda.gov/scripts/ires/index.cfm?Event=91944"/>
    <updated>2023-05-03T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: CGMP Deviations</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/91952/</id>
    <title>Preferred Pharmaceuticals, Inc.: Atorvastatin Calcium Tablets and 16 more</title>
    <link href="https://www.accessdata.fda.gov/scripts/ires/index.cfm?Event=91952"/>
    <updated>2023-04-12T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.</summary>
  </entry>
</feed>
